Memokath™ 028 Prostate
Memokath™ 028 Prostate is a non-allergenic metallic stent used to effectively treat prostatic obstruction without the side-effects of major surgery, or discomfort of catheters.
Memokath™ 028 Prostate is a non-allergenic metallic stent used to effectively treat benign and malignant prostatic obstruction. The stent is inserted in 20-30 minutes under local anesthesia with a cystoscope or a catheter through the urethra and is positioned across the obstruction allowing urine to flow freely through the prostate. Memokath™ 028 Prostate preserves normal bladder control and provides urinary flow without the side-effects of major surgery and discomfort of catheters. It can remain inside the body for up two years or more before needing replacement.
Use of Memokath™ 028 Prostate
Memokath™ 028 Prostate is used for prostatic obstruction whether caused by benign prostatic enlargement (BPH) or prostatic cancer. Memokath™ 028 Prostate treats obstructions without the debilitating side-effects of surgery, and discomfort of catheters making it a preferred choice for patients who wish to avoid these. The minimal invasive nature of Memokath™ 028 Prostate also makes it a sensible choice for patients of high age, frailty, on anticoagulant medicine, or for those suffering from dementia who risk inflicting severe damage and pain on themselves by removing their catheters through force.
Benign prostatic enlargement (BPH)
Malignant prostatic enlargement
Patients of high age or frailty
Patients on anticoagulant medicine
Patients unwilling to undergo surgery
Patients on catheters permanently
Patients with dementia
Patients on waiting list for surgery
Patients with terminal cancer (as palliative treatment)
The insertion of Memokath™ 028 Prostate is performed with flexible (SW) or rigid (TW) cystoscope or using a catheter. It is typically carried out on a day case basis under local anesthesia and normally takes 10-15 minutes. In most cases patients can empty their bladder immediately after Memokath™ 028 Prostate placement and return to daily routines.
Why choose Memokath™ 028 Prostate?
Memokath™ 028 Prostate is chosen as treatment method against prostatic obstruction due to its advantages over competing treatments. Memokath™ 028 Prostate offers a high degree of patient safety and quality of life by avoiding the debilitating side-effects of e.g. impotence, incontinence and urinary tract infections observed with competing treatments. Through e.g. its extended insitu time Memokath™ 028 Prostate is moreover a sound economic choice of treatment, with the potential to save healthcare costs compared to surgery and catherization.
Causes no tissue in-growth
Causes minimum risk of infection
No need for general anaesthesia
Replaces need for surgery
Quality of life
Causes no impotence
Causes no incontinence
Retains voluntary urination control
Replaces need for catheters
Low risk of infection
Fewer switches than with catheters
Out-patient procedure of app. 30 min.
Immediate return to daily activities
Easy to exchange when needed
Immediate symptom relief
Side effects and complications
Memokath™ 028 Prostate generally causes few and only minor side-effects. Blood may occur in the patients’ urine for a period after the insertion, which is normal. Retrograde ejaculation is another known side-effect of Memokath™ 028 Prostate in which case, the patient may decide to remove the stent to regain normal ejaculatory function. The complication risk is also minor and pertains to stent migration or encrustation. If the stent migrates, it can often be repositioned. If not, it can simply be removed or exchanged with a new stent. If the stent encrusts it will typically have to be exchanged. Vigilance by both patients and doctors towards reoccurring symptoms is always recommended in case the stent has migrated as well as to avoid complete encrustation.
Living with Memokath™ 028 Prostate
Memokath™ 028 Prostate typically offers patients a quick return to daily activities after treatment, most often with a substantial decrease in symptoms, and little or no side-effects or complications. Instructing the patients to drink plenty of water will help minimize risk of encrustation. Patient-checkups are advised to ensure the stent continues to function optimally.
For frequently asked questions about Memokath™ 028 Prostate, please refer to our FAQ section.
What treatments should Memokath™ 028 Prostate be considered before?
Memokath™ 028 Prostate should be presented to all relevant patients as part of the treatment options for prostatic obstruction. Memokath™ 028 Prostate has in many cases improved the quality of life for patients living with catheters and would in many cases have been a preferred option for patients who have been treated through surgery, and now suffer from debilitating and permanent side-effects. Consider treatment with Memokath™ 028 Prostate before:
- Foley catheters
- Clean intermittent self-catherization (CISC)
- Transurethral Resection of Prostate (TUR-P)
- Transurethral microwave therapy (TUMT)
- Laser surgery
On anticoagulant medicine
A 72-year old is diagnosed with BPH but is unwilling to be dependent on catheters, and unable undergo surgery due anticoagulant intake. Memokath™ 028 Prostate helped the patient overcome his BPH symptoms without impeding his life quality through continual Foley exchanges or self-catherization.
Continuous urinary tract infections
A 83-year old BPH patient has new foley catheters inserted twice per month, but continues to get urinary tract infections, and suffers from high use of antibiotics. After insertion of Memokath™ 028 Prostate, the patient is relieved of infections, BPH symptoms and bi-monthly catheter switches.
Unwilling to risk surgery side-effects
A 55-year old is faced with the risk of impotence and incontinence as side-effects of TURP-treatment of his newly diagnosed BPH. Determined to avoid risking his sexual life and the outlook of lifelong urinary leakage, the patient chose Memokath™ 028 Prostate as the right solution for him.
Helping the demented avoid self-removal
An 87-year old demented BPH-patient suffers the painful experience of removing his Foley-catheter by force in a moment of forgetfulness to its function. Hidden away inside the prostate, Memokath™ 028 Prostate helped prevent the repeat of the patient’s self-removal and the ensuing pain.
Mitigating symptoms of malignant obstructing
A 78-year old suffers from prostatic obstruction due to a slowly growing prostate cancer. The patient is given a Memokath™ 028 Prostate to enable proper urinary flow while placed under watchful waiting to evaluate the cancer’s development.
How do I become a Memokath™ 028 Prostate user?
Memokath™ 028 Prostate has treated thousands of patients worldwide and continues to gain popularity among urologists as a treatment of prostatic obstruction. To become a user of Memokath™ 028 Prostate you can request a visit from one of our representatives to initiate a training process or participate in one of our regular training workshops displayed under Events. Either way, our product specialists will assist you with your patients on-location until you feel confident with performing the method on your own.
Memokath™ 028 Prostate expands in the distal end from CH 24 to CH 42 and is available for use with flexible cystoscope (SW) or rigid cystoscope (TW). Both versions are available in 30, 35, 40, 45, 50, 60 and 70 mm., as well as in special lengths on request.
Please Contact us to learn more about Memokath™ 028 Prostate or request a visit from one of our product specialists.
Memokath™ – we treat urinary tract obstructions